Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125493661 | 12549366 | 1 | I | 20160706 | 20160710 | 20160712 | 20160712 | EXP | BR-BAYER-2016-135348 | BAYER | 0.00 | F | Y | 0.00000 | 20160712 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125493661 | 12549366 | 1 | PS | Magnevistan | GADOPENTETATE DIMEGLUMINE | 1 | Intravenous (not otherwise specified) | 17 ML, ONCE | 17 | ML | 53577C | 19596 | 17 | ML | SOLUTION FOR INJECTION | 1X |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125493661 | 12549366 | 1 | Nuclear magnetic resonance imaging brain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125493661 | 12549366 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125493661 | 12549366 | Infusion site oedema | |
125493661 | 12549366 | Infusion site pain | |
125493661 | 12549366 | Infusion site thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125493661 | 12549366 | 1 | 20160705 | 20160705 | 0 |